Kodiak Sciences, Inc. (KOD) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Bionano Genomics, Inc.

Cue Biopharma, Inc.

CARA Therapeutics, Inc.

Immunome, Inc.

NGM Biopharmaceuticals, Inc.

Armata Pharmaceuticals, Inc.

Kodiak Sciences, Inc.

IO Biotech, Inc.

Cyteir Therapeutics, Inc.

Anixa Biosciences, Inc.

Omega Therapeutics, Inc.

Why is Kodiak Sciences, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Kodiak Sciences, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Kodiak Sciences, Inc.

-100.0%

6.86

129.32%

S&P 500

13.99%

0.81

19.85%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-187.87%

EBIT to Interest (avg)

-234.55

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

96.73%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.05

EV to EBIT

-0.98

EV to EBITDA

-1.14

EV to Capital Employed

2.41

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-244.58%

ROE (Latest)

-173.39%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD -114.98 MM

NET PROFIT(HY)

Higher at USD -109.87 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

-7What is not working for the Company

NET PROFIT(HY)

At USD -109.87 MM has Grown at -24.64%

ROCE(HY)

Lowest at -140.33%

DEBT-EQUITY RATIO (HY)

Highest at 86.85 %

CASH AND EQV(HY)

Lowest at USD 243.02 MM

Here's what is working for Kodiak Sciences, Inc.

Operating Cash Flow

Highest at USD -114.98 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit

Higher at USD -109.87 MM

than preceding 12 month period ended Jun 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Kodiak Sciences, Inc.

Net Profit

At USD -109.87 MM has Grown at -24.64%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is negative

Net Profit (USD MM)

Debt-Equity Ratio

Highest at 86.85 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Cash and Eqv

Lowest at USD 243.02 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents